The main market opportunities include enhancing pharmaceutical manufacturing quality through advanced cGMP training, reducing violations, and improving operational efficiency by adhering to FDA ...

A new AI platform offers free drug discovery tools to global health researchers, aiming to speed up treatments for malaria, ...

Medtronic, Abbott, Boston Scientific, Medical Microinstruments (MMI) and other device developers earned honors at the 2026 ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

PumasAI, a science-first organization that turns data into life-saving decisions faster, today announced a major presence at the Quantitative Systems Pharmacology Conference (QSPC) 2026 in Leiden, the ...

Insilico Medicine has expanded its Science MMAI Gym, a large-scale training and benchmarking platform for artificial ...

What began as a child's encounter with trauma has grown into a research programme committed to understanding recovery.

RadioMatrix by Stratasys and Siemens enables precise control of radiopacity in 3D-printed anatomical models, improving ...